2016
London, UK, 05 December 2016 BTG plc (LSE: BTG), the global specialist healthcare company, today announces the inclusion of treatment with PneumRx® Coils in guidelines for the management of...
OTTAWA, CANADA, 05 December 2016 Les microsphères radio-opaques à élution médicamenteuse DC Bead LUMIMC offrent aux radiologistes interventionnels du Canada un traitement de nouvelle...
London, UK, 15 November 2016 BTG plc (LSE: BTG), the global specialist healthcare company, today announces its interim results for the six months ended 30 September 2016. Click here to download...
#, 19 October 2016 BTG plc (LSE: BTG), an international specialist healthcare company, today announced that the first patient in Malaysia was treated with TheraSphere™ – a transarterial...
London, UK, 14 October 2016 BTG plc (LSE: BTG), an international specialist healthcare company, with Mirada Medical Ltd, a leading global brand in medical imaging software, today announced CE Mark...
06 October 2016 BTG plc (LSE: BTG), the specialist healthcare company, announces the following update for the six months to 30 September 2016 ahead of the publication of its Interim Results on 15...
London, UK, 06 October 2016 BTG plc (LSE: BTG), the specialist healthcare company, announces that its Biocompatibles, Inc. subsidiary has reached a settlement with the US government in relation to...
London, UK, 09 September 2016 LONDON, UK: BTG plc (LSE: BTG), an international specialist healthcare company, today announced the launch of the βETA™ Radiation Safety Programme, a new...
Ottawa, Canada, 23 August 2016 BTG International Canada Inc., part of the global specialist healthcare company BTG (LSE:BTG), today announced that it has received approval from Health Canada for...
West Conshohocken, PA, 17 August 2016 BTG plc (LSE: BTG), the specialist healthcare company, today announces that Centers for Medicare and Medicaid Services (CMS) has approved a New Technology...
London, UK, 02 August 2016 BTG plc (LSE: BTG), a global specialist healthcare company, today announced that it has obtained European Conformity (CE) Mark from the Notified Body British Standards...
London, UK, 27 July 2016 BTG plc (LSE: BTG), the specialist healthcare company, today announces the appointment of Graham Hetherington as a non-executive director of the Board and Chair of the...
London, UK, 14 July 2016 BTG plc (LSE: BTG), the specialist healthcare company provides the following business update ahead of its Annual General Meeting, which will be held today at 10.30 am at...
West Conshohocken, PA, US, 06 July 2016 BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation...
London, UK, 15 June 2016 BTG plc (LSE: BTG), the specialist healthcare company, is pleased to announce that it has completed the acquisition of Galil Medical, a leading provider of cryoablation...
London, UK, 09 June 2016 BTG, a global leader in interventional oncology, announced today that it has joined the Global Liver Institute’s Partnership Network as a founding member. The Global...
02 June 2016 BTG plc (LSE: BTG), a global specialist healthcare company, today announced plans to initiate the TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in...
WASHINGTON D.C, 26 May 2016 New study highlights potential cost savings when using yttrium-90 glass microspheres for treatment of hepatocellular carcinoma TARE (transarterial radio-embolization)...
London, UK, 17 May 2016 BTG plc (LSE: BTG), the specialist healthcare company, today announces its final results for the year ended 31 March 2016. Click here to download the results release PDF
London, UK, 06 May 2016 Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation market Galil Medical is a leader in cryoablation of...
London, UK, 05 April 2016 Selective internal radiation therapy (SIRT), including TheraSphere®, reimbursed by Zorginstituut Nederland BTG plc (LSE: BTG), a global specialist healthcare company is...
London, UK, 05 April 2016 BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2016 ahead of the publication of its Final Results on 17...
London, UK, 02 April 2016 BTG to initiate multi-centre TARGET study evaluating dosimetry for 90Y radioembolisation therapy in patients with hepatocellular carcinoma BTG plc (LSE: BTG), a global...
London, UK, 01 April 2016 BTG announces US launch of LC Bead LUMI™, ground-breaking radiopaque embolic bead First and only, commercially available, radiopaque embolic bead in the US has...
London, UK, 10 March 2016 DC Bead®, DC BeadM1® and Bead Block® Now Sold Directly to Specialist Physicians Across Canada BTG International Canada Inc., part of the international specialty...